Zobrazeno 1 - 10 of 73 pro vyhledávání: '"Dufourd, T."'
1
Akademický článek
Bioreactor-produced iPSCs-derived dopaminergic neuron-containing neural microtissues innervate and normalize rotational bias in a dose-dependent manner in a Parkinson rat model.
Autor: Prudon N; Université de Bordeaux, CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France. Electronic address: nicolas.prudon@u-bordeaux.fr., Cordero-Espinoza L; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Abarkan M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Gurchenkov B; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Morel C; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Lepleux M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., De Luca V; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Lartigue M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Cabanas H; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Pujol N; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Milvoy L; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Morand P; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Moncaubeig F; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Wurtz H; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Poinçot L; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., De Marco M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Jonckeau A; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Pletenka J; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Luquet E; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Sovera A; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Hardoüin J; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Neves IJ; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Machado-Hitau A; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Schmit K; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Piouceau L; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Guilbert S; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Manache-Alberici L; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Lanero Fidalgo M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Dabée G; Université de Bordeaux, CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; PIV-EXPE, Centre Broca, Université de Bordeaux, F-33000 Bordeaux, France., Dufourd T; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Schroeder J; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Alessandri K; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Bezard E; Université de Bordeaux, CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France., Faggiani E; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France., Feyeux M; TreeFrog Therapeutics, Bât A, F-33600 Pessac, France.
Publikováno v: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2024 Sep; Vol. 21 (5), pp. e00436. Date of Electronic Publication: 2024 Oct 01.
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Hypodopaminergic state of the nigrostriatal pathway drives compulsive alcohol use.
Autor: Goutaudier R; Inserm, U1216, Univ. Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France., Joly F; Inserm, U1216, Univ. Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France., Mallet D; Inserm, U1216, Univ. Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France., Bartolomucci M; Inserm, U1216, Univ. Grenoble Alpes, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France., Guicherd D; Service de Biochimie, Biologie Moléculaire, Toxicologie Environnementale, CHU de Grenoble-Alpes Site Nord - Institut de Biologie et de Pathologie, F-38041, Grenoble, France., Carcenac C; Inserm, U1216, Univ. Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France., Vossier F; Inserm, U1216, Univ. Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France., Dufourd T; Inserm, U1216, Univ. Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France., Boulet S; Inserm, U1216, Univ. Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France., Deransart C; Inserm, U1216, Univ. Grenoble Alpes, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France., Chovelon B; Service de Biochimie, Biologie Moléculaire, Toxicologie Environnementale, CHU de Grenoble-Alpes Site Nord - Institut de Biologie et de Pathologie, F-38041, Grenoble, France.; Univ. Grenoble Alpes, CNRS, DPM, 38000, Grenoble, France., Carnicella S; Inserm, U1216, Univ. Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France. sebastien.carnicella@inserm.fr.
Publikováno v: Molecular psychiatry [Mol Psychiatry] 2023 Jan; Vol. 28 (1), pp. 463-474. Date of Electronic Publication: 2022 Nov 14.
Zobrazit plný text záznamu
5
Akademický článek
A metabolic biomarker predicts Parkinson's disease at the early stages in patients and animal models.
Autor: Mallet D; University Grenoble Alpes, INSERM, U1216, Grenoble Institut Neurosciences, Grenoble, France., Dufourd T; University Grenoble Alpes, INSERM, U1216, Grenoble Institut Neurosciences, Grenoble, France., Decourt M; Université de Poitiers, INSERM U1084, Laboratoire de Neurosciences Expérimentales et Cliniques, Poitiers, France., Carcenac C; University Grenoble Alpes, INSERM, U1216, Grenoble Institut Neurosciences, Grenoble, France., Bossù P; Dipartimento di Neurologia Clinica e Comportamentale, Laboratorio di Neuropsicobiologia Sperimentale, IRCCS Santa Lucia Foundation, Rome, Italy., Verlin L; University Grenoble Alpes, INSERM, US17, CNRS, UMS 3552, CHU Grenoble Alpes, IRMaGe, Grenoble, France., Fernagut PO; Université de Poitiers, INSERM U1084, Laboratoire de Neurosciences Expérimentales et Cliniques, Poitiers, France., Benoit-Marand M; Université de Poitiers, INSERM U1084, Laboratoire de Neurosciences Expérimentales et Cliniques, Poitiers, France., Spalletta G; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy., Barbier EL; University Grenoble Alpes, INSERM, U1216, Grenoble Institut Neurosciences, Grenoble, France.; University Grenoble Alpes, INSERM, US17, CNRS, UMS 3552, CHU Grenoble Alpes, IRMaGe, Grenoble, France., Carnicella S; University Grenoble Alpes, INSERM, U1216, Grenoble Institut Neurosciences, Grenoble, France., Sgambato V; Université de Lyon, CNRS UMR5229, Institut des Sciences Cognitives Marc Jeannerod, Bron, France., Fauvelle F; University Grenoble Alpes, INSERM, U1216, Grenoble Institut Neurosciences, Grenoble, France.; University Grenoble Alpes, INSERM, US17, CNRS, UMS 3552, CHU Grenoble Alpes, IRMaGe, Grenoble, France., Boulet S; University Grenoble Alpes, INSERM, U1216, Grenoble Institut Neurosciences, Grenoble, France.
Publikováno v: The Journal of clinical investigation [J Clin Invest] 2022 Feb 15; Vol. 132 (4).
Zobrazit plný text záznamu
6
Akademický článek
Plasma or serum? A qualitative study on rodents and humans using high-throughput microRNA sequencing for circulating biomarkers.
Autor: Dufourd T; Inserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France., Robil N; Genosplice, Paris, France., Mallet D; Inserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France., Carcenac C; Inserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France., Boulet S; Inserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France., Brishoual S; CIC/CRB INSERM 1402, CHU de Poitiers, France., Rabois E; CIC/CRB INSERM 1402, CHU de Poitiers, France., Houeto JL; CIC/CRB INSERM 1402, CHU de Poitiers, France., de la Grange P; Genosplice, Paris, France., Carnicella S; Inserm, U1216, University Grenoble Alpes, Grenoble Institut des Neurosciences, 38000 Grenoble, France.
Publikováno v: Biology methods & protocols [Biol Methods Protoc] 2019 Jun 25; Vol. 4 (1), pp. bpz006. Date of Electronic Publication: 2019 Jun 25 (Print Publication: 2019).
Zobrazit plný text záznamu
7
Akademický článek
Preanalytical, analytical and postanalytical considerations in circulating microRNAs measurement.
Autor: Zendjabil, Mustapha1,2 zenmustapha@gmail.com
Publikováno v: Biochemia Medica. 2024, Vol. 34 Issue 2, p1-11. 11p.
Zobrazit plný text záznamu
8
Akademický článek
Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson's Disease.
Autor: Kumari, Nitu1 (AUTHOR) nitumicro225@gmail.com, Anand, Santosh1 (AUTHOR) santosh.anand@reva.edu.in, Shah, Kamal2 (AUTHOR) kamal0603@gmail.com, Chauhan, Nagendra Singh3 (AUTHOR) chauhan.nagendra@gmail.com, Sethiya, Neeraj K.4 (AUTHOR) manmohan.singhal@dituniversity.edu.in, Singhal, Manmohan4 (AUTHOR)
Publikováno v: Molecules. Nov2023, Vol. 28 Issue 22, p7588. 28p.
Zobrazit plný text záznamu
9
Akademický článek
Up-regulation of plasma miRNA-21 and miRNA-422a in postmenopausal osteoporosis.
Autor: Mohammadisima, Neda1 (AUTHOR), Farshbaf-khalili, Azizeh2 (AUTHOR) farshbafa@tbzmed.ac.ir, Ostadrahimi, Alireza3 (AUTHOR) farshbafa@tbzmed.ac.ir
Publikováno v: PLoS ONE. 10/18/2023, Vol. 18 Issue 10, p1-14. 14p.
Zobrazit plný text záznamu
10
Akademický článek
Repeated Cocaine Intake Differentially Impacts Striatal D 2/3 Receptor Availability, Psychostimulant-Induced Dopamine Release, and Trait Behavioral Markers of Drug Abuse.
Autor: Urueña-Méndez, Ginna1,2 (AUTHOR) ginna.uruenamendez@unige.ch, Dimiziani, Andrea1 (AUTHOR) belleslidia@gmail.com, Bellés, Lidia1,2 (AUTHOR) raphael.goutaudier@unige.ch, Goutaudier, Raphaël1,2 (AUTHOR), Ginovart, Nathalie1,2 (AUTHOR) nathalie.ginovart@unige.ch
Publikováno v: International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 17, p13238. 19p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje